Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2025-03-11
DOI
https://doi.org/10.1186/s13058-024-01946-y
Citations
4
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Jennifer H. Yearley, Sung‐Bae Kim, Joohyuk Sohn, Javier Cortés et al.
4 citations
Breast Cancer Research
Cancer Immunotherapy and Biomarkers
4.18
article

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Jennifer H. Yearley, Sung‐Bae Kim, Joohyuk Sohn, Javier Cortés, Michael Nebozhyn, Rebecca Dent, Peter Schmid, Eva Muñoz‐Couselo, Theodoros Foukakis, Lingkang Huang, Răzvan Cristescu, Seock‐Ah Im, Vassiliki Karantza, Petar Jelinic, Anran Wang, Esther Holgado, Sherko Kümmel, Yeon Hee Park
article en
4 citations

Abstract

No abstract available for this paper.
Breast Cancer ResearchVol. 27(1)
Ulsan College (KR), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Karolinska University Hospital (SE), Yonsei University (KR), Instituto Cajal (ES), Asan Medical Center (KR), Samsung Medical Center (KR), Seoul National University Hospital (KR), Karolinska Institutet (SE), University of Ulsan (KR), Hospital Quirónsalud Barcelona (ES), Vall d'Hebron Hospital Universitari (ES), National Cancer Centre Singapore (SG), Vall d'Hebron Institute of Oncology (ES), Charité - Universitätsmedizin Berlin (DE), Sungkyunkwan University (KR), Universidad Europea de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 6%
Cancer Immunotherapy and Biomarkers
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.